Insider trading

Period: 120 months Stock: TVTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

352 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

352 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

352 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

352 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
352 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
352 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

352 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
5 Nov 2021
ASELAGE STEVE Director
Sold, plan not stated
$262.30K 10,000 at 26.23
5.8%
2 Nov 2021
ASELAGE STEVE Director · indirect
Sold, plan not stated
$105.00K 3,500 at 30.00
15.2%
1 Nov 2021
ASELAGE STEVE Director · indirect
Sold, plan not stated
$147.40K 5,000 at 29.48
17.9%
7 Oct 2021
ASELAGE STEVE Director
Sold, plan not stated 2×
$1.57M 60,000 at 26.25
24.0%
4 Oct 2021
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$75.75K 3,058 at 24.77
4.8%
17 Aug 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$134.14K 7,836 at 17.12
4.8%
17 Aug 2021
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$24.09K 1,407 at 17.12
2.2%
17 Aug 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$24.09K 1,407 at 17.12
3.6%
17 Aug 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$24.09K 1,407 at 17.12
3.8%
17 Aug 2021
Clague Laura Chief Financial Officer
Sold, plan not stated
$24.09K 1,407 at 17.12
4.3%
17 Aug 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$24.09K 1,407 at 17.12
2.9%
28 Jul 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$17.26K 1,250 at 13.81
2.7%
2 Jun 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$68.59K 4,780 at 14.35
3.1%
1 Jun 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$71.20K 4,782 at 14.89
3.0%
12 May 2021
Clague Laura Chief Financial Officer
Sold, plan not stated
$38.92K 2,000 at 19.46
6.6%
12 May 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$31.62K 1,625 at 19.46
4.5%
12 May 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$30.40K 1,562 at 19.46
4.7%
12 May 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$7.30K 375 at 19.46
0.8%
11 May 2021
ASELAGE STEVE Director
Sold, plan not stated
$42.02K 2,146 at 19.58
1.1%
11 May 2021
Clague Laura Chief Financial Officer
Sold, plan not stated
$38.28K 2,000 at 19.14
6.2%
11 May 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$31.10K 1,625 at 19.14
4.3%
11 May 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$29.92K 1,563 at 19.14
4.5%
11 May 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$7.18K 375 at 19.14
0.8%
16 Apr 2021
ASELAGE STEVE Director
Sold, plan not stated
$262.30K 10,000 at 26.23
5.0%
17 Mar 2021
ASELAGE STEVE Director
Sold, plan not stated 2×
$486.46K 17,727 at 27.44
8.6%
18 Feb 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$35.84K 1,250 at 28.67
3.5%
17 Feb 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$34.19K 1,250 at 27.35
3.3%
8 Feb 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$151.99K 4,813 at 31.58
3.0%
8 Feb 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$71.06K 2,250 at 31.58
5.7%
8 Feb 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$71.06K 2,250 at 31.58
5.6%
8 Feb 2021
Clague Laura Chief Financial Officer
Sold, plan not stated
$71.06K 2,250 at 31.58
6.5%
8 Feb 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$35.53K 1,125 at 31.58
2.4%
8 Feb 2021
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$35.53K 1,125 at 31.58
1.9%
5 Feb 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$151.18K 4,813 at 31.41
2.9%
5 Feb 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated
$70.67K 2,250 at 31.41
5.4%
5 Feb 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated
$70.67K 2,250 at 31.41
5.3%
5 Feb 2021
Clague Laura Chief Financial Officer
Sold, plan not stated
$70.67K 2,250 at 31.41
6.1%
5 Feb 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated
$35.34K 1,125 at 31.41
2.3%
5 Feb 2021
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$35.34K 1,125 at 31.41
1.8%
3 Feb 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated 2×
$104.80K 3,625 at 28.91
8.9%
3 Feb 2021
Clague Laura Chief Financial Officer
Sold, plan not stated 2×
$104.80K 3,625 at 28.91
10.1%
3 Feb 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated 2×
$91.79K 3,175 at 28.91
7.8%
3 Feb 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated
$69.56K 2,406 at 28.91
1.6%
3 Feb 2021
Rosenberg Noah L. Chief Medical Officer
Sold, plan not stated 2×
$52.41K 1,813 at 28.91
3.9%
3 Feb 2021
Heerma Peter Chief Commercial Officer
Sold, plan not stated
$16.28K 563 at 28.91
1.0%
2 Feb 2021
ASELAGE STEVE Director
Sold, plan not stated
$768.75K 25,000 at 30.75
11.3%
2 Feb 2021
Dube Eric M Chief Executive Officer
Sold, plan not stated 2×
$261.27K 8,734 at 29.91
5.5%
2 Feb 2021
ROTE WILLIAM E. Senior Vice President, R&D
Sold, plan not stated 2×
$111.47K 3,625 at 30.75
8.1%
2 Feb 2021
Clague Laura Chief Financial Officer
Sold, plan not stated 2×
$111.47K 3,625 at 30.75
9.2%
2 Feb 2021
REED ELIZABETH E SVP, GC & Corporate Secretary
Sold, plan not stated 2×
$97.63K 3,175 at 30.75
7.2%
Showing 201–250 of 352. ← Newer Page 5 of 8 Older →